Vaccines protect people of all ages against disease. Immunization saves millions of lives every year and vaccines are widely recognized as one of the most successful health interventions. Yet, [...]
TBVI and EVI are building on a strong TB vaccine R&D community To discover and develop the next generation of TB vaccines it will be essential to build on the track record of European [...]
Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization. TRANSVAC2, [...]
NIAID has a new funding opportunity “Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)”. For any questions, applicants are strongly encouraged to contact [...]
Keeping the Promise -a New report from a group of 12 product development partnerships (PDPs) including TBVI
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
